Skip to main content
CRNX logo

CRNX

Crinetics Pharmaceuticals, Inc.
$42.03 -0.20 (-0.47%) At close · Jul 6
Market Cap
$4.43B
Shares
105,440,208

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 244
Total Value: $4,295,564,451
Total Shares: 118,269,941
Showing 1–100 of 250 holdings by value · page 1 of 3

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 244 13F filers
Top Holder
13.3%
Jun 2023 → Mar 2026 · range 6.6% – 13.7%
of institutional value
Top 5
39.8%
Jun 2023 → Mar 2026 · range 29.6% – 43.2%
of institutional value
Top 10
58.6%
Jun 2023 → Mar 2026 · range 48.6% – 63.5%
of institutional value
HHI
468
Jun 2023 → Mar 2026 · range 317 – 528
Broadly held
Showing 100 of 250
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1658247 CUSIP 22663K107 13F (30d) 5 filings 4 filers Visit website Investor relations